Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents antibodies binding IL-4RA

Sep. 20, 2021

JUN identified as a crucial regulator of pathological skin scarring via CD36

Sep. 15, 2021

Genfleet Therapeutics discovers RIP-1 inhibitors

Sep. 9, 2021

LEO Pharma's novel IL-17A/IL-17AR interaction modulator for the oral treatment of psoriasis

Sep. 3, 2021

New melanocortin receptor modulators presented by Palatin Technologies

Sep. 2, 2021

Phase II study of SHR-0302 in alopecia areata meets primary efficacy endpoint

Aug. 26, 2021

Data presented for Almirall's JAK inhibitor LAS-200019

Aug. 26, 2021

Jupiter Wellness submits pre-IND meeting request for JW-100 for eczema

Aug. 24, 2021

Completed phase I studies of ME-3183 pave way for phase II studies in plaque psoriasis

Aug. 24, 2021

DSG3-CAART cells safe in second cohort of DesCAARTes phase I trial

Aug. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...